A team of scientists at the University of Alberta is working to understand why some people respond better to semaglutide, a medication used to regulate blood sugar and appetite, than others. The researchers are investigating the role of energy metabolism in weight loss, a complex process that involves the body's natural response to calorie intake and expenditure. They are also exploring individual factors such as genetics, metabolism, body composition, lifestyle, microbiota, associated diseases, age, and sex that may influence how people respond to semaglutide. The team is using a gold-standard method to measure energy utilization, called a whole-room indirect calorimeter, to study how semaglutide affects energy use in people with blood sugar regulation issues. They are recruiting participants who are about to start semaglutide treatment and will follow their weight loss journey over six months to investigate changes in body weight and composition, and energy utilization. Understanding how semaglutide influences energy use and body composition could help explain why individuals respond differently to weight-loss treatment. This knowledge could lead to more personalized approaches to obesity and Type 2 diabetes management in the future. Additionally, it could help identify potential non-responders to semaglutide and offer alternative treatments sooner in their health journey. The researchers emphasize that current evidence suggests that individuals taking semaglutide or considering starting treatment should make lifestyle changes to support their weight loss efforts. By studying the complex interactions between semaglutide, energy metabolism, and individual factors, the team aims to contribute to a better understanding of weight loss and improve treatment outcomes for people with obesity and Type 2 diabetes.